Home > Research > Publications & Outputs > Subcutaneous omalizumab for people with asthma

Research

Electronic data

  • Donovan_et_al-2021-Cochrane_Database_of_Systematic_Reviews

    Rights statement: This is the version of record of the following protocol: Donovan T, Milan SJ, Adatia A, Solkar Z, Stovold E, Dwan K, Hinks TSC, Crossingham I. Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD014975. DOI: 10.1002/14651858.CD014975. Accessed 19 August 2021 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014975/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Final published version, 147 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Subcutaneous omalizumab for people with asthma

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Subcutaneous omalizumab for people with asthma. / Donovan, T.; Milan, S.J.; Adatia, A. et al.
In: Cochrane Database of Systematic Reviews, Vol. 2021, No. 7, 22.07.2021.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Donovan, T, Milan, SJ, Adatia, A, Solkar, Z, Stovold, E, Dwan, K, Hinks, TSC & Crossingham, I 2021, 'Subcutaneous omalizumab for people with asthma', Cochrane Database of Systematic Reviews, vol. 2021, no. 7. https://doi.org/10.1002/14651858.CD014975

APA

Donovan, T., Milan, S. J., Adatia, A., Solkar, Z., Stovold, E., Dwan, K., Hinks, T. S. C., & Crossingham, I. (2021). Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews, 2021(7). https://doi.org/10.1002/14651858.CD014975

Vancouver

Donovan T, Milan SJ, Adatia A, Solkar Z, Stovold E, Dwan K et al. Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews. 2021 Jul 22;2021(7). doi: 10.1002/14651858.CD014975

Author

Donovan, T. ; Milan, S.J. ; Adatia, A. et al. / Subcutaneous omalizumab for people with asthma. In: Cochrane Database of Systematic Reviews. 2021 ; Vol. 2021, No. 7.

Bibtex

@article{ccb1742752ce4fde9b646a48bf6511a2,
title = "Subcutaneous omalizumab for people with asthma",
abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children. ",
author = "T. Donovan and S.J. Milan and A. Adatia and Z. Solkar and E. Stovold and K. Dwan and T.S.C. Hinks and I. Crossingham",
note = "This is the version of record of the following protocol: Donovan T, Milan SJ, Adatia A, Solkar Z, Stovold E, Dwan K, Hinks TSC, Crossingham I. Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD014975. DOI: 10.1002/14651858.CD014975. Accessed 19 August 2021 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014975/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving. ",
year = "2021",
month = jul,
day = "22",
doi = "10.1002/14651858.CD014975",
language = "English",
volume = "2021",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - Subcutaneous omalizumab for people with asthma

AU - Donovan, T.

AU - Milan, S.J.

AU - Adatia, A.

AU - Solkar, Z.

AU - Stovold, E.

AU - Dwan, K.

AU - Hinks, T.S.C.

AU - Crossingham, I.

N1 - This is the version of record of the following protocol: Donovan T, Milan SJ, Adatia A, Solkar Z, Stovold E, Dwan K, Hinks TSC, Crossingham I. Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD014975. DOI: 10.1002/14651858.CD014975. Accessed 19 August 2021 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014975/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

PY - 2021/7/22

Y1 - 2021/7/22

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children. 

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children. 

U2 - 10.1002/14651858.CD014975

DO - 10.1002/14651858.CD014975

M3 - Journal article

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 7

ER -